(Q55465380)

12 July 2018

title

[Predictive role of EGFR mutation status on postoperative prognosis in patients with resected lung adenocarcinomas]. (English)

1 reference

12 July 2018

1 reference

Yu Dong

1

1 reference

12 July 2018

Ying Li

2

1 reference

12 July 2018

Hong Peng

3

1 reference

12 July 2018

Bo Jin

4

1 reference

12 July 2018

Aimi Huang

5

1 reference

12 July 2018

Hao Bai

6

1 reference

12 July 2018

Hui Xiong

7

1 reference

12 July 2018

Baohui Han

8

1 reference

12 July 2018

language of work or name

Chinese

0 references

publication date

1 April 2013

1 reference

12 July 2018

Chinese Journal of Lung Cancer

published in

1 reference

12 July 2018

volume

16

1 reference

12 July 2018

issue

4

1 reference

12 July 2018

page(s)

177-183

1 reference

12 July 2018

Cancer incidence and mortality in china, 2007.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non-small cell lung cancer patients.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Epithelial growth factor receptor mutation status to the effective of survival in non-small cell lung cancer after surgery

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Clinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutations.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Epidermal growth factor receptor genotype in plasma DNA and outcome of chemotherapy in the Chinese patients with advanced non-small cell lung cancer.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

[Role of EGFR mutation status in patients with stage III non-squamous non-small cell lung cancer treated with chemoradiotherapy].

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: investigation of significantly related factors on CT, FDG-PET, and histopathology

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6000592

Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma

12 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23601297

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23601297

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3779/J.ISSN.1009-3419.2013.04.02

1 reference

12 July 2018

PMC publication ID

6000592

1 reference

12 July 2018

PubMed publication ID

23601297

1 reference

12 July 2018